UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance
UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance is a paper indexed in ScholarIQ from OpenAlex.
How many citations does UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance have?
UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance has 139 citations in the OpenAlex counts ScholarIQ stores.
When was UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance published?
UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance has 2020 year in the ScholarIQ index.
What is the open-access status of UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance?
UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance has hybrid oa status in the ScholarIQ index.
What is the DOI of UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance?
The DOI for UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance is on the source record.
What is the PMID of UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance?
The PMID for UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance is on the source record.
What is the OpenAlex record for UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance?
The OpenAlex for UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance is on the source record.